Study Stopped
PI has decided to close the study.
Subchondral Perfusion Mapping Using Indocyanin Green Laser
ICG
Differential Subchondral Perfusion Mapping Using Indocyanin Green Laser Angiography
1 other identifier
interventional
2
1 country
1
Brief Summary
Laser Angiography using indocyanin green (ICG) is a relatively new technique and has been utilized to assess the viability of soft tissue, most prominently in the general surgery and plastic surgery literature. This technique has been used for prediction of soft tissue viability by assessing the perfusion status. There is currently no Orthopaedic literature regarding the use of this device for assessment of subchondral perfusion of articular surfaces such as the distal femur or other chondral surfaces. In this pilot study, the use of ICG to detect the perfusion status of a distal femur and proximal tibia during a surgical approach to the knee and correlating this to visible signs of arthritis. For example, due to the difference visible with ICG angiography correlate to gross changes in the cartilage health visible to the naked eye with radiographic imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 27, 2016
CompletedFirst Posted
Study publicly available on registry
September 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJanuary 7, 2020
January 1, 2020
1.5 years
September 27, 2016
January 6, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Differential Subchondral Perfusion Mapping using Indocyanin Green Laser Angiography
Visible grade of chondromalacia from the 6 points mentioned above. * Video will be acquired using the Spy Elite or Pinpoint system of the distal femur or proximal tibial surface. Currently, the software with the SPY elite is able to quantify the degree of dye uptake, and this dye uptake number from the 6 points will also be recorded. * Video data will be given a key that corresponds to the subject, thus no videos will be labelled with patient data or information chondromalacia ondromalacia from the 6 points mentioned above. * Video will be acquired using the Spy Elite or Pinpoint system of the distal femur or proximal tibial surface. Currently, the software with the SPY elite is able to quantify the degree of dye uptake, and this dye uptake number from the 6 points will also be recorded. * Video data will be given a key that corresponds to the subject, thus no videos will be labelled with patient data or information
15 months
Study Arms (1)
Indocyanin Green Dye (ICG)
OTHEROnce the patient is in the operating room, the operative intervention will take proceed as current standard protocol dictates for the described procedure. No changes in operative technique will be undertaken apart from injection of the dye and visualization with the camera. After the articular surface of the distal femur or proximal tibia has been exposed, 2.5 mg of indocyanin green will be injected intravenously by anesthetist through a pre-existing IV line outside the sterile field. The operating surgeon will grade 6 locations on a standard scale of chondromalacia or cartilage damage.
Interventions
Eligibility Criteria
You may qualify if:
- Patients undergoing elective orthopedic intervention in which the distal femoral or proximal tibial articular surface is visualized through arthroscopic or open technique
You may not qualify if:
- Iodine allergy
- Intolerance to indocyanine green dye
- Active infection at surgical site
- Known pregnancy
- Inability to comprehend consent process
- Age \<18 or \> 89
- Significant blood loss risk without tourniquet inflation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loma Linda University Healthcare Department of Orthopaedic Surgery
Loma Linda, California, 92354, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Lee Zuckerman, MD
Loma Linda University Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 27, 2016
First Posted
September 28, 2016
Study Start
June 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
January 7, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share